Latest Circulars: (IPC) Indian Pharmacopoeia Commission

Important Notifications / Notices / Circulars by IPC

1852
Indian Pharmacopoeia Commission IPC
IPC
SDCO Cum Licensing Authority |
Food and Drugs Administration, (FDA) Haryana, India. |
Email ID: dahiya19@yahoo.com
Rakesh Dahiya

Last Updated on December 30, 2023 by The Health Master

Download Latest Circulars: (IPC) Indian Pharmacopoeia Commission

Download Latest Circulars: (IPC) Indian Pharmacopoeia Commission: Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare, Govt. of India. The IPC was created to set standards for drugs in the country.

Its basic function is to regularly update the standards of drugs commonly required for the treatment of diseases prevailing in this region.

It publishes official documents for improving the quality of medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).

We have provided a list of impurities, a list of reference substances and important notifications, notices and circulars by IPC (Source: IPC website. Click the below links:

Laboratory
Picture: Pixabay

List of impurities

For List of Impurities, click the below link:

Rate-list-of-Impurities

List of Reference Standards

For List of Reference Standards, click the below link:

List of Phytopharmaceutical Reference Substances

List of Phytopharmaceutical Reference Substances available at IPC Ghaziabad, click below link:

List of IPRS available at IPC, Ghaziabad

List-of-Phtopharmaceutical-Reference-Substances-available-at-IPC-Ghaziabad


Important Notifications / Notices / Circulars by IPC

2023

IPC dt 02-02-2023 Outcome of Pharmacovigilance Programme of India (PvPI) for taking appropriate regulatory actions

IPC-dt-02-02-2023-Outcome-of-Pharmacovigilance-Programme-of-India-PvPI-for-taking-appropriate-regulatory-actions.

IPC dt 31-01-2023 List of suspected drugs which are associated with the Adverse Drug Reaction

IPC-dt-31-01-2023-List-of-suspected-drugs-which-are-associated-with-the-Adverse-Drug-Reaction

IPC dt 13-01-2023 Amendment list 002 to IP-2022

IPC-dt-13-01-2023-Amendment-list-002-to-IP-2022

2022

IPC dt 13-12-2022 Corrigendum to amendment list 01 of IP 2022

IPC-dt-13-12-2022-Corringedum-to-amendment-list-01-of-IP-2022

IPC dt 28-11-2022 Amendment List 01 to IP 2022

IPC-dt-28-11-2022-Amendment-List-01-to-IP-2022

IPC Notice dt 27-10-2022 Clarifies on uniformity of dosage units & impurities in IP 2022

IPC-Notice-dt-27-10-2022-Clarifies-on-uniformity-of-dosage-units-impurities-in-IP-2022

IPC dt 26-10-2022 Draft Amendments for comments IP 2022

IPC-dt-26-10-2022-Draft-Amendments-for-comments-IP-2022

2021

IPC dt 30-12-2021 – Amendment List-09 to IP-2018

IPC-dt-30-12-2021-Amendment-List-09-to-IP-2018

IPC dt 16-09-2021 – Guidance document on Calibration of Gas Chromatograph

IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-Gas-Chromatograph

IPC dt 16-09-2021 – Guidance document on Calibration of HPLC

IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-HPLC

IPC dt 16-09-2021 – Guidance document on Compliance with Indian Pharmacopoeia Standards

IPC-dt-16-09-2021-Guidance-document-on-Compliance-with-Indian-Pharmacopoeia-Standards

IPC dt 16-09-2021 – Guidance document on Good Documentation Practices

IPC-dt-16-09-2021-Guidance-document-on-Good-Documentation-Practices

IPC dt 16-09-2021 – Guidance document on Legal Status of Indian Pharmacopoeia

IPC-dt-16-09-2021-Guidance-document-on-Legal-Status-of-Indian-Pharmacopoeia

IPC dt 16-09-2021 – Guidance document on Process for Development of Indian Pharmacopoeia Monographs

IPC-dt-16-09-2021-Guidance-document-on-Process-for-Development-of-Indian-Pharmacopoeia-Monographs

IPC dt 16-09-2021 – Guidance document on Quality Management System in Testing Laboratory

IPC-dt-16-09-2021-Guidance-document-on-Quality-Management-System-in-Testing-Laboratory

IPC dt 16-09-2021 – Guidance document on Validation of Analytical Methods

IPC-dt-16-09-2021-Guidance-document-on-Validation-of-Analytical-Methods

IPC Notice dt 26-07-2021 – IP Addendum 2021 shall be effective from 31-12-2021

IPC-Notice-dt-26-07-2021-IP-Addendum-2021-shall-be-effective-from-31-12-2021

IPC dt 24-06-21 – Revised Draft General Chapter on Approach to Alternative Microbiological Methods

IPC-dt-24-06-21-Revised-Draft-General-Chapter-on-Approach-to-Alternative-Microbiological-Methods

IPC 10-03-2021 – Omission of Monographs of ‘Lorcaserin Hydrochloride Hemihydrate’ and Lorcaserin Tablets’ from the Indian Pharmacopoeia

IPC-10-03-2021-Omission-of-Monographs-of-Lorcaserin-Hydrochloride-Hemihydrate-and-Lorcaserin-Tablets-from-the-Indian-Pharmacopoeia

IPC dt 26-02-2021 – Clarification on Alternative Methods in the Indian Pharmacopoeia

IPC-dt-26-02-2021-Clarification-on-Alternative-Methods-in-the-Indian-Pharmacopoeia

IPC dt 25-02-2021 – Amendment List-08 to IP-2018

IPC-dt-25-02-2021-Amendment-List-08-to-IP-2018

IPC 19-02-2021 – Release of Guidance Document for Drafting and Formatting of Monographs for Indian Pharmacopoeia

IPC-19-02-2021-Release-of-Guidance-Document-for-Drafting-and-Formatting-of-Monographs-for-Indian-Pharmacopoeia

IPC dt 12-01-2021 – Draft of General Notices on Phytopharmaceutical Drugs

IPC-dt-12-01-2021-Draft-of-General-Notices-on-Phytopharmaceutical-Drugs

Guidance documents by IPC

IPC dt 16-09-2021 – Guidance document on Calibration of Gas Chromatograph

IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-Gas-Chromatograph

IPC dt 16-09-2021 – Guidance document on Calibration of HPLC

IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-HPLC

IPC dt 16-09-2021 – Guidance document on Compliance with Indian Pharmacopoeia Standards

IPC-dt-16-09-2021-Guidance-document-on-Compliance-with-Indian-Pharmacopoeia-Standards

IPC dt 16-09-2021 – Guidance document on Good Documentation Practices

IPC-dt-16-09-2021-Guidance-document-on-Good-Documentation-Practices

IPC dt 16-09-2021 – Guidance document on Legal Status of Indian Pharmacopoeia

IPC-dt-16-09-2021-Guidance-document-on-Legal-Status-of-Indian-Pharmacopoeia

IPC dt 16-09-2021 – Guidance document on Process for Development of Indian Pharmacopoeia Monographs

IPC-dt-16-09-2021-Guidance-document-on-Process-for-Development-of-Indian-Pharmacopoeia-Monographs

IPC dt 16-09-2021 – Guidance document on Quality Management System in Testing Laboratory

IPC-dt-16-09-2021-Guidance-document-on-Quality-Management-System-in-Testing-Laboratory

IPC dt 16-09-2021 – Guidance document on Validation of Analytical Methods

IPC-dt-16-09-2021-Guidance-document-on-Validation-of-Analytical-Methods

IPC Alerts

Click the below links to read full details:

IPC flags drug safety alert against Minoxidil

IPC alert: About Norfloxacin induced skin hyperpigmentation

IPC alerts about Cefoperazone induced coagulopathy

IPC flags safety alert against immunosuppressive drug Tacrolimus

IPC flags safety alert against Blood Pressure drug, Losartan

IPC flags safety alert against most common Drug Ibuprofen – NSAID

IPC flags safety alert against Covid-19 drug Remdesivir

IPC flags safety alert against NSAID Diclofenac

IPC flags safety alert against Dimethyl Fumarate & Cefazolin

Safety alert against Hepatitis C drug Sofosbuvir: IPC

IPC flags Safety Alerts against these drugs interaction

IPC sounds safety alerts against these Medicines

National Indian Pharmacopoeia (IP) 2022

Indian Pharmacopoeia 2022 salient features, click the link below:

Indian-Pharmacopoeia-2022-salient-features


For other Notifications / Notices / Circulars by IPC, Click here


Online purchase: procedure

Books: IP and NFI

IP Reference Substances

Impurity Standards


Latest Circulars, Notices & Guidelines: CDSCO, DCGI

Latest Circulars by ICMR on Pharmaceuticals

Latest Circulars by the Govt of India, Dept of Pharmaceuticals, Health Ministry

Latest Circulars: (IPC) Indian Pharmacopoeia Commission





Compiled by:
Rakesh DahiyaSDCO cum Licensing Authority, FDA Haryana



For more Notifications on following topics, click below links:

Banned Drugs

Blood Bank / Centre

Cosmetics

COTPA

DPCO / NPPA

Drug Rules

Drugs Act

DMROA

EC Act

General

Homoeopathic

Hospital – RMI

Medical Devices

NDPS Act

New Drugs

Testing Laboratories

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news